Changing prescription patterns for lithium and valproic acid in old age: Shifting practice without evidence

British Medical Journal

Volumn 326, Issue 7396, 2003, Pages 960-961

  Shulman, Kenneth I ^a   Rochon, Paula ^c   Sykora, Kathy ^b   Anderson, Geoffrey ^b   Mamdani, Muhammad ^b   Bronskill, Susan ^b   Tran, Chau T T ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^c Kunin Lunenfeld Applied Research Unit and Department of Food and Nutrition Services and Baycrest Centre for Geriatric Care   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM; VALPROIC ACID;

AGED; ARTICLE; BIPOLAR DISORDER; CLINICAL PRACTICE; DEMENTIA; DRUG CHOICE; DRUG INDICATION; GERIATRIC PATIENT; HUMAN; MAJOR CLINICAL STUDY; PRESCRIPTION; PRIORITY JOURNAL;

EID: 0038076487     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.326.7396.960     Document Type: Article

References (5)

1. Macritchie KA, Geddes JR, Scott J, Haslam DR, Goodwin GM. Valproic acid, valproate and divalproex in the maintenance of bipolar disorder. Cochrane Database Syst Rev 9001;(3):CD003196.
2. Sival RC, Haffmans J, Jansen P, Duursma SA. Sodium valproate in the treatment of aggressive behaviour in patients with dementia - randomized placebo controlled clinical trial. Int J Ger Psychiatry 2002;17:579-85.
3. Dinan TG. Lithium in bipolar mood disorder. BMJ 2009;324:989-90.
4. Johnson G. Lithium - early development, toxicty, and renal function. Neuropsychopharmacology 1998;19:200-5.
5. Baldessarini RJ, Tondo L, Viguera AC. Discontinuing lithium maintenance treatment in bipolar disorders: risks and implications. Bipolar Dis 1999:1(Pt 1);17-24.